OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 5.1 EUR 1.29% Market Closed
Market Cap: 114m EUR

Wall Street
Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 16.83 EUR with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.

Lowest
Price Target
12.63 EUR
148% Upside
Average
Price Target
16.83 EUR
230% Upside
Highest
Price Target
22.37 EUR
339% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
SRZN
Surrozen Inc
352% Upside
PRAX
Praxis Precision Medicines Inc
126% Upside
GILD
Gilead Sciences Inc
8% Upside
KMDA
Kamada Ltd
90% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
45% Upside
PRME
Prime Medicine Inc
197% Upside
688520
Sinocelltech Group Ltd
5% Downside
ORKA
Oruka Therapeutics Inc
252% Upside

Revenue
Forecast

Revenue Estimate
OSE Immunotherapeutics SA

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is -27%.

N/A
Past Growth
-27%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

Net Income
Forecast

Net Income Estimate
OSE Immunotherapeutics SA

The compound annual growth rate of OSE Immunotherapeutics SA's net income for the next 3 years is -52%.

N/A
Past Growth
-52%
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSE's stock price target?
Price Target
16.83 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 16.83 EUR with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.

What is OSE Immunotherapeutics SA's Revenue forecast?
Projected CAGR
-27%

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is -27%.

What is OSE Immunotherapeutics SA's Net Income forecast?
Projected CAGR
-52%

The compound annual growth rate of OSE Immunotherapeutics SA's net income for the next 3 years is -52%.

Back to Top